MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer

Biomedicine and Pharmacotherapy

Volumn 68, Issue 5, 2014, Pages 589-595

  Chen, Xiaochun ^a   Chen, Shaomu ^a   Hang, Weijie ^a   Huang, Haitao ^a   Ma, Haitao ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Chemotherapy; MiR 95; NSCLC; Radiotherapy; SNX1; Tumor growth

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA 95; SORTING NEXIN; SORTING NEXIN 1; UNCLASSIFIED DRUG; MIRN95 MICRORNA, HUMAN; SNX1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER TISSUE; CHEMOSENSITIZATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER CELL LINE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; RADIOSENSITIVITY; RADIOSENSITIZATION; UPREGULATION; ANIMAL; CELL PROLIFERATION; DISEASE COURSE; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MOLECULAR GENETICS; NON SMALL CELL LUNG CANCER; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; RADIATION TOLERANCE; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE, NUDE; MICRORNAS; MOLECULAR SEQUENCE DATA; RADIATION TOLERANCE; SORTING NEXINS; UP-REGULATION;

EID: 84905126318     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.04.008     Document Type: Article

References (33)

1. Zu Y., Ban J., Xia Z., Wang J., Cai Y., Ping W., et al. Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations. Biochem Biophys Res Commun 2013, 430:529-534.
2. Zhao B., Han H., Chen J., Zhang Z., Li S., Fang F., et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett 2014, 342:43-51.
3. Liu Z.L., Wang H., Liu J., Wang Z.X. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 2013, 372:35-45.
4. Yuan Y., Shen Y., Xue L., Fan H. miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor. PloS One 2013, 8:e73604.
5. Zhang C., Ge S., Hu C., Yang N., Zhang J. MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer. Acta Biochim Biophys Sin (Shanghai) 2013, 45:1055-1061.
6. Zhao W.Y., Wang Y., An Z.J., Shi C.G., Zhu G.A., Wang B., et al. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer. Biochem Biophys Res Commun 2013, 435:466-471.
7. Zhang N., Wei X., Xu L. miR-150 promotes the proliferation of lung cancer cells by targeting P53. FEBS Lett 2013, 587:2346-2351.
8. Schliekelman M.J., Gibbons D.L., Faca V.M., Creighton C.J., Rizvi Z.H., Zhang Q., et al. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 2011, 71:7670-7682.
9. Kumar M.S., Erkeland S.J., Pester R.E., Chen C.Y., Ebert M.S., Sharp P.A., et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 2008, 105:3903-3908.
10. Chen G., Umelo I.A., Lv S., Teugels E., Fostier K., Kronenberger P., et al. miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PloS One 2013, 8:e60317.
11. Liu X., Sempere L.F., Ouyang H., Memoli V.A., Andrew A.S., Luo Y., et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 2010, 120:1298-1309.
12. Li Y., Zhang D., Chen C., Ruan Z., Li Y., Huang Y. MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell 2012, 23:1423-1434.
13. Liu X-h, Lu K-h, Wang K-m, Sun M., Zhang E-b, Yang J-s, et al. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer 2012, 12:348.
14. Cheng A.M., Byrom M.W., Shelton J., Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005, 33:1290-1297.
15. Zhang Y., Li M., Wang H., Fisher W.E., Lin P.H., Yao Q., et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg 2009, 33:698-709.
16. Huang Z., Huang S., Wang Q., Liang L., Ni S., Wang L., et al. MicroRNA-95 promotes cell proliferation and targets sorting nexin 1 in human colorectal carcinoma. Cancer Res 2011, 71:2582-2589.
17. Nohata N., Hanazawa T., Kikkawa N., Sakurai D., Sasaki K., Chiyomaru T., et al. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Int J Oncol 2011, 39:1099-1107.
18. Wu C.D., Kuo Y.S., Wu H.C., Lin C.T. MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells. J Biomed Sci 2011, 18:80.
19. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103:2257-2261.
20. Calin G.A., Croce C.M. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006, 66:7390-7394.
21. Ventura A., Jacks T. miRNAs and cancer: a little RNA goes a long way. Cell 2009, 136:586.
22. Rosell R., Wei J., Taron M. Circulating microRNA signatures of tumor-derived exosomes for early diagnosis of non-small-cell lung cancer. Clin Lung Cancer 2009, 10:8-9.
23. Li J., Yang H., Li Y., Liu Y., Chen S., Qi C., et al. microRNA-146 upregulation predicts the prognosis of non-small cell lung cancer by miRNA in situ hybridization. Exp Mol Pathol 2014, 96:195-199.
24. Seike M., Goto A., Okano T., Bowman E.D., Schetter A.J., Horikawa I., et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 2009, 106:12085-12090.
25. Wei J., Gao W., Zhu C.J., Liu Y.Q., Mei Z., Cheng T., et al. Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer. Chin J Cancer 2011, 30:407-414.
26. Liu J., Lu K.H., Liu Z.L., Sun M., De W., Wang Z.X. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1. BMC Cancer 2012, 12:519.
27. Huang X., Jia Z. Construction of HCC-targeting artificial miRNAs using natural miRNA precursors. Exp Ther Med 2013, 6:209-215.
28. Piva R., Spandidos D.A., Gambari R. From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review). Int J Oncol 2013, 43:985-994.
29. Nguyen L.N., Holdren M.S., Nguyen A.P., Furuya M.H., Bianchini M., Levy E., et al. Sorting nexin 1 downregulation promotes colon tumorigenesis. Clin Cancer Res 2006, 12:6952-6959.
30. Nishimura Y., Takiguchi S., Yoshioka K., Nakabeppu Y., Itoh K. Silencing of SNX1 by siRNA stimulates the ligand-induced endocytosis of EGFR and increases EGFR phosphorylation in gefitinib-resistant human lung cancer cell lines. Int J Oncol 2012, 41:1520-1530.
31. Zhang Y., Yang H., Qiu Y., Deng Q., Liu J., Zhao M., et al. Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer. Med Oncol 2014, 31:803.
32. Dziadziuszko R., Holm B., Skov B.G., Osterlind K., Sellers M.V., Franklin W.A., et al. Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy. Ann Oncol 2007, 18:447-452.
33. Dziadziuszko R., Hirsch F.R., Varella-Garcia M., Bunn P.A. Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization-why, when, and how?. Clin Cancer Res 2006, 12:4409s-4415s.